**Core Concept:** Post-transplant lymphoproliferative disorder (PTLD) is a group of diseases that develop in transplant recipients due to Epstein-Barr virus (EBV) infection. EBV is a common human herpesvirus that can establish lifelong latency in the host cell. It plays a crucial role in the development of PTLD, which can manifest as either B-cell lymphoproliferative disorders (B-PTLD) or T-cell lymphoproliferative disorders (T-PTLD).

**Why the Correct Answer is Right:** The correct answer is EBV (Epstein-Barr virus). EBV is the most common virus associated with post-transplant lymphoproliferative disorders (PTLD). It is a common human herpesvirus that causes latent infections in the host cells, leading to abnormal cell proliferation and development of PTLD. EBV infection is particularly significant in solid organ transplantation and haematopoietic stem cell transplantation.

**Why Each Wrong Option is Incorrect:**

A. CMV (Cytomegalovirus): Although CMV can cause PTLD, it is less common than EBV in this context.
B. HIV (Human Immunodeficiency Virus): HIV is primarily associated with PTLD in immunocompromised patients, not post-transplant recipients.
C. HHV8 (Human Herpesvirus 8): HHV8 is the causative agent for Kaposi's sarcoma, not PTLD.
D. Human Herpesvirus 6: HHV6 is also associated with PTLD, but EBV is more common and significant in this context.

**Clinical Pearl:** Understanding the role of EBV in PTLD is crucial for transplant physicians, as prevention and management strategies differ based on the causative virus. EBV-positive PTLD typically responds to antiviral therapy, whereas CMV-positive PTLD may require antiviral therapy and/or immunosuppression reduction.

**Correct Answer:** EBV (Epstein-Barr virus)